Literature DB >> 18925700

Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases.

Marina B Mosunjac1, J Bruce Sundstrom, Mario I Mosunjac.   

Abstract

AIM: To describe a subset of cases with the unusual clinical and histomorphological presentation of anaplastic large cell lymphoma (ALCL) mimicking fever of unknown origin (FUO) and sepsis.
METHODS: A pathology database was searched using full term Systematized Nomenclature of Medicine codes for ALCL to identify 23ALCL cases from the period 1999-2006. Of those, five cases that did not have a correct premortem diagnosis were further analyzed to elucidate the reasons for delayed and incorrect pre-mortem diagnosis. The analyzed data included clinical presentation, duration of symptoms, duration of hospital stay, premortem presumed cause of death, white blood cell count, platelet count, anion gap and blood pH, liver enzymes (alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, alkaline phosphatase), lactate, coagulation tests (prothrombin time, partial thromboplastin time, fibrinogen, D-dimers), microbiology cultures, and radiology and surgical pathology reports. Autopsy reports were reviewed for description of major gross findings, initial clinical diagnosis, and cause of death.
RESULTS: Five fatal and pre-mortem unrecognized ALCL cases were characterized by rapid decline, with histologic findings showing predominantly extranodal involvement, intravascular lymphomatosis, and hemophagocytosis. The cases were also characterized by unusual clinical manifestations including a FUO, sepsis, and disseminated intravascular coagulation-like picture, lactic acidosis, hepatosplenomegaly, and absence of significant peripheral adenopathy.
CONCLUSIONS: There is a distinct group of ALCLs with unique and specific clinical, gross autopsy, and histopathologic findings. Recognition of this clinical variant may facilitate early detection and potentially timely diagnosis and therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18925700      PMCID: PMC2582359          DOI: 10.3325/cmj.2008.5.660

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  42 in total

1.  Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.

Authors:  Santiago Osorio; Carmen Bernis; Rafael de La Cámara
Journal:  Haematologica       Date:  2002-02       Impact factor: 9.941

2.  Symptomatic lactic acidosis due to relapse of T-cell acute lymphoblastic leukaemia in the kidney.

Authors:  Bart De Keulenaer; Steven Van Outryve; Adelard De Backer; Lode Van Overbeke; Ronny Daelemans; Erik Van Marck; Dirk Schepens; Dianne Stephens
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

Review 3.  Primary CNS lymphoma.

Authors:  Fred H Hochberg; Joachim M Baehring; Ephraim P Hochberg
Journal:  Nat Clin Pract Neurol       Date:  2007-01

4.  Large-cell anaplastic (Ki-1-positive) lymphoma complicated by disseminated intravascular coagulation.

Authors:  D Arber; J Bilbao; S Bassion
Journal:  Arch Pathol Lab Med       Date:  1991-02       Impact factor: 5.534

Review 5.  Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants.

Authors:  M Ponzoni; M R Terreni; F Ciceri; A J M Ferreri; S Gerevini; N Anzalone; M Valle; S Pizzolito; G Arrigoni
Journal:  Ann Oncol       Date:  2002-11       Impact factor: 32.976

6.  Primary anaplastic large cell lymphoma of the kidney.

Authors:  Ioannis D Venizelos; Vasilios Rombis; Stavros Tulupidis; Vasiliki Garipidou
Journal:  Leuk Lymphoma       Date:  2003-02

Review 7.  Primary pancreatic anaplastic large cell lymphoma, ALK negative: a case report.

Authors:  Christos-G Savopoulos; N-E Tsesmeli; G-D Kaiafa; A-T Zantidis; M-T Bobos; A-I Hatzitolios; S-T Papavramidis; I-S Kostopoulos
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 8.  Lactic acidosis and other mitochondrial disorders.

Authors:  P W Stacpoole
Journal:  Metabolism       Date:  1997-03       Impact factor: 8.694

9.  Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation.

Authors:  K Okajima; M Uchiba; K Murakami; H Okabe; K Takatsuki
Journal:  Am J Hematol       Date:  1997-03       Impact factor: 10.047

10.  [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients].

Authors:  B Pfaffenbach; K Donhuijsen; J Pahnke; R Bug; R J Adamek; M Wegener; D Ricken
Journal:  Med Klin (Munich)       Date:  1994-06-15
View more
  10 in total

1.  Clinical characteristics and prognostic factors of lymphoma patients initially presenting with fever of unknown origin.

Authors:  Min Wu; Fulati Wulipan; Jiexian Ma; Wensi Qian; Shunrong Sun; Pingping Chen; Yu Xu; Mingyue Chen; Wenjing Yang; Yanhui Xie; Lin Shen
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

3.  Flow cytometry as a diagnostic tool in the early diagnosis of aggressive lymphomas mimicking life-threatening infection.

Authors:  Nikolaos J Tsagarakis; Nektaria A Kentrou; Georgios Kakiopoulos; Georgios Androutsos; Athanasios Galanopoulos; Christos Michaelidis; Dimitra Rontogianni; Apostolos Tolis; Stavroula Chini; Georgios Gortzolidis; Konstantinos A Papadimitriou; Dimitra Skoumi; Konstantina Tzanetou; Georgios Paterakis
Journal:  Case Rep Med       Date:  2011-06-05

4.  Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection.

Authors:  Sven Grützmeier; Anna Porwit; Corinna Schmitt; Eric Sandström; Börje Åkerlund; Ingemar Ernberg
Journal:  Infect Agent Cancer       Date:  2016-08-22       Impact factor: 2.965

5.  Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis.

Authors:  Zhou Yu; Yifan Pang; Linda Wang; Daniel E Ezekwudo; Foluso Ogunleye; Susanna S Gaikazian; Mark Micale; James Huang; Ann Marie Blenc; Ishmael Jaiyesimi
Journal:  Case Rep Hematol       Date:  2017-09-24

6.  Unusual clinical presentation of anaplastic large cell lymphoma.

Authors:  Fernando Peixoto Ferraz de Campos; Maria Claudia Nogueira Zerbini; Aloisio Felipe-Silva; Angélica Braz Simões; Silvana Maria Lovisolo; Leonardo Gomes da Fonseca; Lorena Laborda
Journal:  Autops Case Rep       Date:  2014-03-31

7.  ALK+ Anaplastic Large Cell Lymphoma With Bladder Involvement Presenting as Fever of Unknown Origin: A Case Report and Literature Review.

Authors:  Joshua Lawrenz; Justin Tomal; James Towne; Beth Johnson; Brent Rieger
Journal:  World J Oncol       Date:  2013-05-06

8.  ALK+ Anaplastic large cell lymphoma with extensive cardiac involvement: A rare case report and review of the literature.

Authors:  Kaniyappan Nambiyar; Kirti Gupta; Uma Debi; Saroj Kant Sinha; Rakesh Kochhar
Journal:  Autops Case Rep       Date:  2021-01-28

9.  Lymphoma in autopsy cases.

Authors:  Ahmad Alkhasawneh; Aysha Mubeen; Arun Gopinath
Journal:  Forensic Sci Med Pathol       Date:  2018-06-23       Impact factor: 2.456

10.  Differential protein expression in patients with urosepsis.

Authors:  Xu-Kai Yang; Nan Wang; Cheng Yang; Yang-Min Wang; Tuan-Jie Che
Journal:  Chin J Traumatol       Date:  2018-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.